The Board of Direors of Enochian BioSciences InInc. expressed unanimous and strong affirmation of the current position of the Company, the Management and the promising advancement of the Research and Development pipeline. The strong affirmation of the Company by the Board follows the unexpected and shocking release by the Department of Justice that Dr. Serhat Gumrukçu, an inventor and co-founder of the Company, has been arrested and charged with serious crimes that are reported to have occurred prior to the merger which created the Company. The Board announces the appointment of Greg Alton, former interim CEO and General Counsel of Gilead Sciences, as Lead Independent Board member.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +1.36% | +4.93% | -53.00% |
05-24 | Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy | MT |
05-24 | Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy | CI |
1st Jan change | Capi. | |
---|---|---|
-53.00% | 220M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RENB Stock
- News Renovaro Inc.
- Enochian Biosciences Announces the Appointment of Greg Alton as Lead Independent Board Member